Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01993225
Brief Title: A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

First Submitted : November 13, 2013
First Submitted that Met QC Criteria : November 20, 2013
First Posted : November 25, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : September 29, 2014
Last Update Posted : October 1, 2014 (Estimate)